Background: Asleep deep brain stimulation (aDBS) implantation replaces microelectrode recording for image-guided implantation, shortening the operative time and reducing cerebrospinal fluid egress. This may decrease pneumocephalus, thus decreasing brain shift during implantation. Objective: To compare the incidence and volume of pneumocephalus during awake (wkDBS) and aDBS procedures. Methods: A retrospective review of bilateral DBS cases performed at Oregon Health & Science University from 2009 to 2017 was undertaken. Postimplantation imaging was reviewed to determine the presence and volume of intracranial air and measure cortical brain shift. Results: Among 371 patients, pneumocephalus was noted in 66% of wkDBS and 15.6% of aDBS. The average volume of air was significantly higher in wkDBS than aDBS (8.0 vs. 1.8 mL). Volumes of air greater than 7 mL, which have previously been linked to brain shift, occurred significantly more frequently in wkDBS than aDBS (34 vs 5.6%). wkDBS resulted in significantly larger cortical brain shifts (5.8 vs. 1.2 mm). Conclusions: We show that aDBS reduces the incidence of intracranial air, larger air volumes, and cortical brain shift. Large volumes of intracranial air have been correlated to shifting of brain structures during DBS procedures, a variable that could impact accuracy of electrode placement.

Keywords:
Deep brain stimulation, Asleep deep brain stimulation, Pneumocephalus, Brain shift, Stereotactic error
1.
Benabid AL, Benazzouz A, Hoffmann D, Limousin P, Krack P, Pollak P: Long-term electrical inhibition of deep brain targets in movement disorders. Mov Disord 1998; 13(suppl 3): 119–125.
2.
Deuschl G, Schade-Brittinger C, Krack P, Volkmann J, Schäfer H, Bötzel K, et al: A randomized trial of deep-brain stimulation for Parkinson’s disease. N Engl J Med 2006; 355: 896–908.
3.
Weaver FM, Follett KA, Stern M, Luo P, Harris CL, Hur K, et al: Randomized trial of deep brain stimulation for Parkinson disease: thirty-six-month outcomes. Neurology 2012; 79: 55–65.
4.
Deep-Brain Stimulation for Parkinson’s Disease Study Group; Obeso JA, Olanow CW, Rodriguez-Oroz MC, Krack P, Kumar R, et al: Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson’s disease. N Engl J Med 2001; 345: 956–963.
5.
Holtzheimer PE, Mayberg HS: Deep brain stimulation for psychiatric disorders. Annu Rev Neurosci 2011; 34: 289–307.
6.
Baizabal-Carvallo J-F, Kagnoff MN, Jimenez-Shahed J, Fekete R, Jankovic J: The safety and efficacy of thalamic deep brain stimulation in essential tremor: 10 years and beyond. J Neurol Neurosurg Psychiatr 2014; 85: 567–572.
7.
Eggington S, Valldeoriola F, Chaudhuri KR, Ashkan K, Annoni E, Deuschl G: The cost-effectiveness of deep brain stimulation in combination with best medical therapy, versus best medical therapy alone, in advanced Parkinson’s disease. J Neurol 2014; 261: 106–116.
8.
Krack P, Batir A, van Blercom N, Chabardes S, et al: Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson’s…. New England Journal of Medicine 2003; 349: 1925–1934.
9.
Chopra A, Klassen B, Stead SM: Current clinical application of deep-brain stimulation for essential tremor. Neuropsychiatr Dis Treat 2013; 9: 1859–1865.
10.
Okun MS, Tagliati M, Pourfar M, Fernandez HH, Rodriguez RL, Alterman RL, et al: Management of referred deep brain stimulation failures: a retrospective analysis from 2 movement disorders centers. Arch Neurol 2005; 62: 1250–1255.
11.
Ellis T-M, Foote KD, Fernandez HH, Sudhyadhom A, Rodriguez RL, Zeilman P, et al: Reoperation for suboptimal outcomes after deep brain stimulation surgery. Neurosurgery 2008; 63: 754–760, discussion 760–761.
12.
Anheim M, Batir A, Fraix VR, Silem M, Chabardès S, Seigneuret E, et al: Improvement in Parkinson disease by subthalamic nucleus stimulation based on electrode placement. Arch Neurol 2008; 65: 612–616.
13.
Richardson RM, Ostrem JL, Starr PA: Surgical repositioning of misplaced subthalamic electrodes in Parkinson’s disease: location of effective and ineffective leads. Stereotact Funct Neurosurg 2009; 87: 297–303.
14.
Azmi H, Machado A, Deogaonkar M, Rezai A: Intracranial air correlates with preoperative cerebral atrophy and stereotactic error during bilateral STN DBS surgery for Parkinson’s disease. Stereotact Funct Neurosurg 2011; 89: 246–252.
15.
Elias WJ, Fu K-M, Frysinger RC: Cortical and subcortical brain shift during stereotactic procedures. J Neurosurg 2007; 107: 983–988.
16.
Halpern CH, Danish SF, Baltuch GH, Jaggi JL: Brain shift during deep brain stimulation surgery for Parkinson’s disease. Stereotact Funct Neurosurg 2007; 86: 37–43.
17.
Khan MF, Mewes K, Gross RE, Krinjar O: Assessment of brain shift related to deep brain stimulation surgery. Stereotact Funct Neurosurg 2007; 86: 44–53.
18.
Miyagi Y, Shima F, Sasaki T: Brain shift: an error factor during implantation of deep brain stimulation electrodes. J Neurosurg 2007; 107: 989–997.
19.
Nazzaro JM, Lyons KE, Honea RA, Mayo MS, Cook-Wiens G, Harsha A, et al: Head positioning and risk of pneumocephalus, air embolism, and hemorrhage during subthalamic deep brain stimulation surgery. Acta Neurochir 2010; 152: 2047–2052.
20.
Obuchi T, Katayama Y, Kobayashi K, Oshima H, Fukaya C, Yamamoto T: Direction and predictive factors for the shift of brain structure during deep brain stimulation electrode implantation for advanced Parkinson’s disease. Neuromodulation 2008; 11: 302–310.
21.
Burchiel KJ, McCartney S, Lee A, Raslan AM: Accuracy of deep brain stimulation electrode placement using intraoperative computed tomography without microelectrode recording. J Neurosurg 2013; 119: 301–306.
22.
Zrinzo L, Foltynie T, Limousin P, Hariz MI: Reducing hemorrhagic complications in functional neurosurgery: a large case series and systematic literature review. J Neurosurg 2012; 116: 84–94.
23.
Benabid A-L, Pollak P, Gao D, Hoffmann D, Limousin P, Gay E, et al: Chronic electrical stimulation of the ventralis intermedius nucleus of the thalamus as a treatment of movement disorders. J Neurosurg 1996; 84: 203–214.
24.
Favre J, Taha JM, Baumann T, Burchiel KJ: Computer analysis of the tonic, phasic, and kinesthetic activity of pallidal discharges in Parkinson patients. Surg Neurol 1999; 51: 665–673.
25.
Broderick JP, Brott TG, Grotta JC: Intracerebral hemorrhage volume measurement. Stroke 1994; 25: 1081.
26.
Hunsche S, Sauner D, Maarouf M, Poggenborg JOR, Lackner K, Sturm V, et al: Intraoperative X-ray detection and MRI-based quantification of brain shift effects subsequent to implantation of the first electrode in bilateral implantation of deep brain stimulation electrodes. Stereotact Funct Neurosurg 2009; 87: 322–329.
27.
Slotty PJ, Kamp MA, Wille C, Kinfe TM, Steiger HJ, Vesper J: The impact of brain shift in deep brain stimulation surgery: observation and obviation. Acta Neurochir 2012; 154: 2063–2068.
28.
Brodsky MA, Anderson S, Murchison C, Seier M, Wilhelm J, Vederman A, et al: Clinical outcomes of asleep vs awake deep brain stimulation for Parkinson disease. Neurology 2017; 89: 1944–1950.
29.
Winkler D: The first evaluation of brain shift during functional neurosurgery by deformation field analysis. J Neurol Neurosurg Psychiatr 2005; 76: 1161–1163.
30.
Elias WJ, Sansur CA, Frysinger RC: Sulcal and ventricular trajectories in stereotactic surgery. J Neurosurg 2009; 110: 201–207.
31.
Ivan ME, Yarlagadda J, Saxena AP, Martin AJ, Starr PA, Sootsman WK, et al: Brain shift during bur hole-based procedures using interventional MRI. J Neurosurg 2014; 121: 149–160.
32.
Ostrem JL, Galifianakis NB, Markun LC, Grace JK, Martin AJ, Starr PA, et al: Clinical outcomes of PD patients having bilateral STN DBS using high-field interventional MR-imaging for lead placement. Clin Neurol Neurosurg 2013; 115: 708–712.
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.